SARS-CoV-2 biology and host interactions

S Steiner, A Kratzel, GT Barut, RM Lang… - Nature Reviews …, 2024 - nature.com
The zoonotic emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and the ensuing coronavirus disease 2019 (COVID-19) pandemic have profoundly affected …

Computational design of mRNA vaccines

YA Kim, K Mousavi, A Yazdi, M Zwierzyna, M Cardinali… - Vaccine, 2024 - Elsevier
Abstract mRNA technology has emerged as a successful vaccine platform that offered a swift
response to the COVID-19 pandemic. Accumulating evidence shows that vaccine efficacy …

SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1

S Zhang, J Wang, L Wang, S Aliyari… - Cellular & molecular …, 2022 - nature.com
Most deaths from the COVID-19 pandemic are due to acute respiratory distress syndrome
(ARDS)-related respiratory failure. Cytokine storms and oxidative stress are the major …

Comparative analysis of SARS-CoV-2 variants of concern, including omicron, highlights their common and distinctive amino acid substitution patterns, especially at …

M Nikolaidis, A Papakyriakou, K Chlichlia… - Viruses, 2022 - mdpi.com
In order to gain a deeper understanding of the recently emerged and highly divergent
Omicron variant of concern (VoC), a study of amino acid substitution (AAS) patterns was …

[HTML][HTML] Emerging SARS-CoV-2 variants: Why, how, and what's next?

Y Chen, Q Liu, L Zhou, Y Zhou, H Yan, K Lan - Cell Insight, 2022 - Elsevier
The emergence of the SARS-CoV-2 Omicron variant poses a striking threat to human
society. More than 30 mutations in the Spike protein of the Omicron variant severely …

SARS‐CoV‐2 NSP7 inhibits type I and III IFN production by targeting the RIG‐I/MDA5, TRIF, and STING signaling pathways

J Deng, Y Zheng, SN Zheng, ML Nan… - Journal of Medical …, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a poor inducer of innate
antiviral immunity, and the underlying mechanism still needs further investigation. Here, we …

Bisubstrate inhibitors of severe acute respiratory syndrome coronavirus-2 nsp14 methyltransferase

E Jung, R Soto-Acosta, J Xie, DJ Wilson… - ACS Medicinal …, 2022 - ACS Publications
Taking advantage of the uniquely constricted active site of SARS-CoV-2 Nsp14
methyltransferase, we have designed bisubstrate inhibitors interacting with the SAM and …

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase

C Meyer, A Garzia, MW Miller, DJ Huggins, RW Myers… - Nature, 2024 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) 1. The rapid development of highly effective …

SARS-CoV-2 and the DNA damage response

RJ Grand - Journal of General Virology, 2023 - microbiologyresearch.org
The recent coronavirus disease 2019 (COVID-19) pandemic was caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is characterized by …

The reassessed potential of SARS-CoV-2 attenuation for COVID-19 vaccine development—A systematic review

M Goławski, P Lewandowski, I Jabłońska, M Delijewski - Viruses, 2022 - mdpi.com
Live-attenuated SARS-CoV-2 vaccines received relatively little attention during the COVID-
19 pandemic. Despite this, several methods of obtaining attenuated coronaviruses are …